Role of TNF-α produced by nonantigen-specific cells in a fulminant hepatitis mouse model

Journal of Immunology

Volumn 182, Issue 1, 2009, Pages 391-397

  Ito, Hiroyasu ^a   Ando, Kazuki ^a,b   Ishikawa, Tetsuya ^c   Saito, Kuniaki ^a,d   Takemura, Masao ^a   Imawari, Michio ^e   Moriwaki, Hisataka ^a   Seishima, Mitsuru ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Goto Clinic   (Japan)

^c Nagoya Kyoritsu Hospital   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; AUTACOID; EPITOPE;

ADOPTIVE TRANSFER; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; DOSE RESPONSE; HEPATITIS; HISTOPATHOLOGY; INFLAMMATORY CELL; LIVER CELL; LIVER INJURY; LIVER NECROSIS; MACROPHAGE; MALE; MONONUCLEAR CELL; MORTALITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANIMAL HEPATITIS; BIOSYNTHESIS; C57BL MOUSE; CELL CLONE; COMPARATIVE STUDY; DISEASE MODEL; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; LIVER FAILURE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SECRETION; TRANSGENIC MOUSE; TRANSPLANTATION; TUMOR CELL LINE; VIROLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CLONE CELLS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; EPITOPES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS, VIRAL, ANIMAL; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIVER FAILURE, ACUTE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; T-LYMPHOCYTES, CYTOTOXIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59849094902     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.1.391     Document Type: Article

References (28)

1. + T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77: 68-76.
2. Ishikawa, T., D. Kono, J. Chung, P. Fowler, A. Theofilopoulos, S. Kakumu, and F. V. Chisari. 1998. Polyclonality and multispecificity of the CTL response to a single viral epitope. J. Immunol. 161: 5842-5850.
3. Nakamoto, Y., L. G. Guidotti, V. Pasquetto, R. D. Schreiber, and F. V. Chisari. 1997. Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice. J. Immunol. 158: 5692-5697.
4. Guidotti, L. G., T. Ishikawa, M. V. Hobbs, B. Matzke, R. Schreiber, and F. V. Chisari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4: 25-36.
5. Shresta, S., C. T. Pham, D. A. Thomas, T. A. Graubert, and T. J. Ley. 1998. How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 10: 581-587.
6. Ando, K., T. Moriyama, L. G. Guidotti, S. Wirth, R. D. Schreiber, H. J. Schlicht, S. N. Huang, and F. V. Chisari. 1993. Mechanisms of class I restricted immunopathology: a transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178: 1541-1554.
7. Muto, Y., K. T. Nouri-Aria, A. Meager, G. J. Alexander, A. L. Eddleston, and R. Williams. 1988. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 2: 72-74.
8. Zylberberg, H., A. C. Rimaniol, S. Pol, A. Masson, D. De Groote, P. Berthelot, J. F. Bach, C. Brechot, and F. Zavala. 1999. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J. Hepatol. 30: 185-191.
9. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10: 411-452.
10. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
11. Ando, K., K. Hiroishi, T. Kaneko, T. Moriyama, Y. Muto, N. Kayagaki, H. Yagita, K. Okumura, and M. Imawari. 1997. Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J. Immunol. 158: 5283-5291.
12. Braun, M. Y., B. Lowin, L. French, H. Acha-Orbea, and J. Tschopp. 1996. Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease. J. Exp. Med. 183: 657-661.
13. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265: 528-530.
14. Taniguchi, T., M. Takata, A. Ikeda, E. Momotani, and K. Sekikawa. 1997. Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor α-deficient mice. Lab. Invest. 77: 647-658.
15. Ohteki, T., R. Okuyama, S. Seki, T. Abo, K. Sugiura, A. Kusumi, T. Ohmori, H. Watanabe, and K. Kumagai. 1992. Age-dependent increase of extrathymic T cells in the liver and their appearance in the periphery of older mice. J. Immunol. 149: 1562-1570.
16. Trobonjaca, Z., F. Leithauser, P. Moller, R. Schirmbeck, and J. Reimann. 2001. Activating immunity in the liver, I: liver dendritic cells (but not hepatocytes) are potent activators of IFN-γ release by liver NKT cells. J. Immunol. 167: 1413-1422.
17. Meyer, R. A., and M. C. Duffy. 1993. Spontaneous reactivation of chronic hepatitis B infection leading to fulminant hepatic failure: report of two cases and review of the literature. J. Clin. Gastroenterol. 17: 231-234.
18. Wright, T. L., and J. Y. Lau. 1993. Clinical aspects of hepatitis B virus infection. Lancet 342: 1340-1344.
19. Chisari, F. V. 1995. Hepatitis B virus transgenic mice: insights into the virus and the disease. Hepatology 22: 1316-1325.
20. Sugiyama, M., Y. Tanaka, T. Kato, E. Orito, K. Ito, S. K. Acharya, R. G. Gish, A. Kramvis, T. Shimada, N. Izumi, et al. 2006. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology 44: 915-924.
21. Ozasa, A., Y. Tanaka, E. Orito, M. Sugiyama, J. H. Kang, S. Hige, T. Kuramitsu, K. Suzuki, E. Tanaka, S. Okada, et al. 2006. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 44: 326-334.
22. Kondo, T., T. Suda, H. Fukuyama, M. Adachi, and S. Nagata. 1997. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 3: 409-413.
23. Saunders, B. P., T. Masaki, T. Sawada, S. Halligan, R. K. Phillips, T. Muto, and C. B. Williams. 1995. A peroperative comparison of Western and Oriental colonic anatomy and mesenteric attachments. Int. J. Colorectal. Dis. 10: 216-221.
24. Moriyama, T., S. Guilhot, K. Klopchin, B. Moss, C. A. Pinkert, R. D. Palmiter, R. L. Brinster, O. Kanagawa, and F. V. Chisari. 1990. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 248: 361-364.
25. Ando, K., L. G. Guidotti, S. Wirth, T. Ishikawa, G. Missale, T. Moriyama, R. D. Schreiber, H. J. Schlicht, S. N. Huang, and F. V. Chisari. 1994. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol. 152: 3245-3253.
26. Streetz, K., L. Leifeld, D. Grundmann, J. Ramakers, K. Eckert, U. Spengler, D. Brenner, M. Manns, and C. Trautwein. 2000. Tumor necrosis factor α in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 119: 446-460.
27. Halder, R. C., S. Seki, A. Weerasinghe, T. Kawamura, H. Watanabe, and T. Abo. 1998. Characterization of NK cells and extrathymic T cells generated in the liver of irradiated mice with a liver shield. Clin. Exp. Immunol. 114: 434-447.
28. Gilles, P. N., D. L. Guerrette, R. J. Ulevitch, R. D. Schreiber, and F. V. Chisari. 1992. HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-γ. Hepatology 16: 655-663.